XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
  Dialysis
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Nov 17th, 2006 - 22:35:04

Nephrology Channel
subscribe to Nephrology newsletter

Latest Research : Nephrology

   DISCUSS   |   EMAIL   |   PRINT
Obese kidney donors are as safe as other donors
Feb 18, 2005, 16:24, Reviewed by: Dr.



 
Mayo Clinic researchers have found that obese individuals in otherwise good health who donated a kidney had outcomes similar to their non-obese counterparts.

In a retrospective study of more than 500 patients, at an average of eleven months after kidney donation, Mayo doctors found obese donors did not experience more problems than non-obese donors. However, prior to donation, obese patients were at greater risk for cardiovascular disease based on blood pressure and cholesterol levels, compared to normal weight donors. Despite the findings, the study emphasizes the importance of following obese patients for a longer time before drawing any long-term conclusions.

Historically living kidney donation has been restricted to a select donor group in very good health. However, with national trends indicating an increased obese population in the United States, the number of obese individuals offering to donate a kidney to a friend or loved one is rising. Recognizing this trend, Mayo physicians reviewed the extensive living donor experience at Mayo to examine outcomes in obese donors.

"We know that obesity is rising in our population, and while that is not a good trend, we need to see if obesity poses a specific risk for kidney donors," says Sandra Taler, M.D., a Mayo Clinic kidney specialist and a co-author of the study. "We found that short-term outcomes for obese donors did not differ significantly from outcomes experienced by donors of normal weight. Additional follow-up is definitely needed to see if there are long-term differences, but these initial findings are encouraging."

As the largest living donor organ transplant program in the United States, Mayo Clinic encourages live organ donations. Because a typical wait for a kidney from a deceased donor can range from three to five years, many people will not survive long enough on dialysis to reach transplantation.

More than 300,000 Americans suffer from kidney failure requiring dialysis to live. Life expectancies increase from about four years with dialysis, to 15 years with a kidney transplant. Despite the superior survival and better quality of life with a transplant, only about 5 percent of dialysis patients will receive a transplant in the United States, due to a limited supply of donor organs.
 

- The study is published in the March issue of the American Journal of Transplantation.
 

Mayo Clinic

 
Subscribe to Nephrology Newsletter
E-mail Address:

 

Other authors of the study include: Julie Heimbach, M.D., Mikel Prieto, M.D., Fernando Cosio, M.D., Stephen Textor, M.D., Yogish Kudva, M.B.B.S, George Chow, M.D., Michael Ishitani, M.D., Timothy Larson, M.D., and Mark Stegall, M.D. The full article is available at: www.blackwell-synergy.com.

Related Nephrology News

Kidney stones? Have some orange juice!!!
NOTCH2 gene mutations linked to Alagille syndrome
Fetal hydronephrosis mystery solved
Alport Syndrome: From Pathogenesis to a Potential Therapy
Meckel-Gruber syndrome gene identified- a help to understand polycystic kidney disease
Dialysis patients may be overmedicated
Mycophenolate mofetil may be more effective in inducing lupus nephritis remission
Dialysis patients often have close family members also on dialysis - Study
Prognosis Improving For Diabetics With End Stage Renal Disease
Osmolytes critical to survival of kidney cells


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us